TY  - GENERIC
DO  - 10.20944/preprints202104.0780.v1
UR  - http://dx.doi.org/10.20944/preprints202104.0780.v1
TI  - Response to Combination of Pembrolizumab and Axitinib in Hereditary Leyomiomatosis and Renal Cell Cancer (HLRCC)
T2  - Preprints
AU  - Gurruchaga Sotés, Ibon
AU  - Santander Lobera, Carmen
PY  - 2021
DA  - 2021/04/29
PB  - Preprints